Valion Bio, Inc. (VBIO)
NASDAQ · Manufacturing · Pharmaceutical preparations
$2.96−$0.5200 (−14.94%) on the dayAs of the close; data may be delayed.
VBIO price, last 12 months
Key stats
- Previous close
- $3.48
- Open
- $3.19
- Day range
- $2.79 – $3.82
- 52-week range
- $2.05 – $32.50
- Volume
- 733.2K
- Avg volume (20 days)
- 860.6K
- Market cap
- $2.7M
Performance
1W+39.6%
1M−24.1%
3M−78.7%
6M—
YTD—
1Y—
Technicals and fundamentals
About Valion Bio, Inc.
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.7M